Investigating d-cycloserine as a potential pharmacological enhancer of an emotional bias-learning procedure
The partial NMDA receptor agonist d-cycloserine (DCS) may enhance psychological therapies. However, its exact mechanism of action is still being investigated. Cognitive Bias Modification (CBM) techniques allow isolation of cognitive processes and thus investigation of how they may be affected by DCS...
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Journal article |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2018
|